References
- Aquilonius S. M., Hedstrand U. The use of physostigmine as an antidote in tricyclic antidepressant intoxication. Acta Anaesthesiol Scand 1978; 22: 40–45
- Kleinwachter Beobachtungen uber die Wirkung des Calabar Extracts gegen Atropinvergiftung. Berl Klin Wschr 1864; 11: 369
- Burks J. S., Walker J. E., Rumack B. H., Ott J. E. Tricyclic antidepressant poisoning. Reversal of coma, choreoathetosis, and myoclonus by physostigmine. JAMA 1974; 230: 1405–1407
- Pentel P., Peterson C. D. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med 1980; 9: 588–590
- Newton R. W. Physostigimine salicylate in the treatment of tricyclic antidepressant overdosage. JAMA 1975; 231: 941–943
- Vance M. A., Ross S. M., Millinigton W. R., Blumberg J. B. Potentiation of tricyclic antidepressant toxicity by physostigmine in mice. Clin Toxicol 1977; 11: 413–421
- Baum P. A., Barkovich A. J., Koch T. K., Berg B. O. Deep gray matter involvement in children with acute disseminated encephalomyelitis. Am J Neuroradiol 1994; 15: 1275–1283
- Hart M. N., Earle K. M. Haemorrhagic and perivenous encephalitis: A clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 1975; 38: 585–591
- Loizzo A., Longo V. EEG effects of cholinergic and anticholinergic drugs. The Handbook of Electroencephalography and Clinical Neurophysiology, A. Remond, 1977; 7C: 7–22
- Santucci V., Glatt A., Demieville H., Olpe H. R. Quantification of slow-wave EEG induced by atropine: Effects of physostigmine, amphetamine and haloperidol. Eur J Pharmacol 1981; 73: 113–122
- Miura Y., Ito T., Kadokawa T. Acute EEg changes in rats by brainstem ischemia and its dopaminergic involvement. Jpn J Pharmacol 1985; 39: 443–451
- Gustafson L., Edvinsson L., Dahlgren N., et al. Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG. Psychopharmacology Berl 1987; 93: 31–35